WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Effect of Resvida, a Comparison With Calorie Restriction Regimen
Not Applicable
Completed
- Conditions
- ObesityMetabolic SyndromeDiabetesAging
- Interventions
- Dietary Supplement: resveratrolOther: placeboBehavioral: Calorie Restriction
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 58
- Registration Number
- NCT00823381
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
Phase 4
Completed
- Conditions
- Chronic Kidney DiseaseSecondary Hyperparathyroidism
- Interventions
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2014-08-07
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 110
- Registration Number
- NCT00823303
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Northshore University Health System, Evanston, Illinois, United States
🇺🇸Washington University, St. Louis, Missouri, United States
Regulation of Hepatic Insulin Extraction
Withdrawn
- Conditions
- Diabetes
- First Posted Date
- 2008-12-18
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT00811044
MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine
Phase 4
Completed
- Conditions
- Apnea of PrematurityBrain InjuryIntraventricular Hemorrhage
- Interventions
- First Posted Date
- 2008-12-16
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 74
- Registration Number
- NCT00809055
- Locations
- 🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States
Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
Phase 1
Completed
- Conditions
- Metastatic Breast Cancer
- Interventions
- Biological: Mammaglobin-A DNA vaccine
- First Posted Date
- 2008-12-12
- Last Posted Date
- 2015-01-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT00807781
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
Sex Steroids, Sleep, and Metabolic Dysfunction in Women
Not Applicable
Completed
- Conditions
- Polycystic Ovary Syndrome (PCOS)Obstructive Sleep ApneaObesity
- Interventions
- Device: continuous positive airway pressureOther: Control
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 61
- Registration Number
- NCT00805207
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT00802815
- Locations
- 🇺🇸
Washington University Department of Neurology, Saint Louis, Missouri, United States
A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain
Not Applicable
Terminated
- Conditions
- Metastases
- Interventions
- Radiation: Stereotactic radiotherapy
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2014-12-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 2
- Registration Number
- NCT00802659
- Locations
- 🇺🇸
Washington University, St. Louis, Missouri, United States
Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2017-02-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT00802880
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
The Effect of an Azygos Vein Coil on Defibrillation Threshold
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Device: Standard configuration vs. azygos coil
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2018-09-28
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 32
- Registration Number
- NCT00798174
- Locations
- 🇺🇸
Washington University, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath